Literature DB >> 7698045

Osteopenia, neurological dysfunction, and the development of Charcot neuroarthropathy.

M J Young1, A Marshall, J E Adams, P L Selby, A J Boulton.   

Abstract

OBJECTIVE: To determine factors that might be associated with the development of Charcot neuroarthropathy. RESEARCH DESIGN AND METHODS: This cross-sectional prevalence study examined neurological function and bone density in matched groups of neuropathic diabetic patients with and without radiological evidence of Charcot neuroarthropathy.
RESULTS: Patients with Charcot neuroarthropathy had a global impairment of neurological function that was significantly greater than that of otherwise matched non-Charcot neuropathic patients. All 17 Charcot patients had evidence of autonomic neuropathy compared with 10 of the control subjects (P = 0.03). The Charcot patients had evidence of reduced bone density in the lower limbs compared with the neuropathic control subjects (P = 0.009), but relatively preserved bone density in the spine (P = 0.4 vs. control subjects).
CONCLUSIONS: We conclude that minor trauma in diabetic patients with peripheral neuropathy might result in a fracture in those with a reduced bone density and thus trigger the development of Charcot neuroarthropathy.

Entities:  

Mesh:

Year:  1995        PMID: 7698045     DOI: 10.2337/diacare.18.1.34

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  36 in total

Review 1.  Utilization of advanced modalities in the management of diabetic Charcot neuroarthropathy.

Authors:  Jennifer Pappalardo; Ryan Fitzgerald
Journal:  J Diabetes Sci Technol       Date:  2010-09-01

Review 2.  Diabetic neuropathy in older adults.

Authors:  Kara A Witzke; Aaron I Vinik
Journal:  Rev Endocr Metab Disord       Date:  2005-05       Impact factor: 6.514

Review 3.  Theories concerning the pathogenesis of the acute charcot foot suggest future therapy.

Authors:  William J Jeffcoate
Journal:  Curr Diab Rep       Date:  2005-12       Impact factor: 4.810

Review 4.  Diabetic neuropathy in older adults.

Authors:  Aaron I Vinik; Elsa S Strotmeyer; Abhijeet A Nakave; Chhaya V Patel
Journal:  Clin Geriatr Med       Date:  2008-08       Impact factor: 3.076

5.  Inflammatory osteolysis in diabetic neuropathic (charcot) arthropathies of the foot.

Authors:  David R Sinacore; Mary K Hastings; Kathryn L Bohnert; Faye A Fielder; Dennis T Villareal; Vilray P Blair; Jeffrey E Johnson
Journal:  Phys Ther       Date:  2008-09-18

6.  A Candidate Imaging Marker for Early Detection of Charcot Neuroarthropathy.

Authors:  Paul K Commean; Kirk E Smith; Charles F Hildebolt; Kathryn L Bohnert; David R Sinacore; Fred W Prior
Journal:  J Clin Densitom       Date:  2017-06-28       Impact factor: 2.617

7.  Volumetric quantitative computed tomography measurement precision for volumes and densities of tarsal and metatarsal bones.

Authors:  Paul K Commean; Jared A Kennedy; Karen A Bahow; Charles F Hildebolt; Lu Liu; Kirk E Smith; Mary K Hastings; Tao Ju; Fred W Prior; David R Sinacore
Journal:  J Clin Densitom       Date:  2011-07-01       Impact factor: 2.617

Review 8.  Exploring microRNAs in diabetic chronic cutaneous ulcers: Regulatory mechanisms and therapeutic potential.

Authors:  Xuqiang Nie; Jiufeng Zhao; Hua Ling; Youcai Deng; Xiaohui Li; Yuqi He
Journal:  Br J Pharmacol       Date:  2020-08-13       Impact factor: 8.739

Review 9.  Diabetes and disordered bone metabolism (diabetic osteodystrophy): time for recognition.

Authors:  S Epstein; G Defeudis; S Manfrini; N Napoli; P Pozzilli
Journal:  Osteoporos Int       Date:  2016-03-15       Impact factor: 4.507

Review 10.  Update on Charcot neuroarthropathy.

Authors:  E B Jude; A J Boulton
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.